Amicus Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FOLD and other ETFs, options, and stocks.About FOLD
Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio.
FOLD Key Statistics
Stock Snapshot
As of today, Amicus Therapeutics(FOLD) shares are valued at $14.25. The company's market cap stands at 4.41B, with a P/E ratio of -318.79.
On 2025-12-28, Amicus Therapeutics(FOLD) stock moved within a range of $14.23 to $14.28. With shares now at $14.25, the stock is trading +0.1% above its intraday low and -0.2% below the session's peak.
Trading activity shows a volume of 5.18M, compared to an average daily volume of 29.48M.
Over the past 52 weeks, Amicus Therapeutics(FOLD) stock has traded between a high of $14.36 and a low of $5.51.
Over the past 52 weeks, Amicus Therapeutics(FOLD) stock has traded between a high of $14.36 and a low of $5.51.
FOLD News
BofA moved to No Rating from Buy on Amicus Therapeutics (FOLD) after the company announced that it has entered into an agreement to be acquired by BioMarin (BMR...
Amicus Therapeutics (FOLD) has quietly delivered a strong run lately, with the stock climbing over 30% in the past month and roughly 65% over the past 3 months....
